IRAK-4 as the central TIR signaling mediator in innate immunity
about
Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6Helical assembly in the death domain (DD) superfamilyTIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signalingNF-kappaB-related genetic diseasesNegative regulation of Toll-like-receptor signaling by IRF-4.Rice XB15, a protein phosphatase 2C, negatively regulates cell death and XA21-mediated innate immunity.Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses.Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.TLR8: an innate immune receptor in brain, neurons and axons.Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligandsDiscovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4.Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites.IRAK4 gene polymorphism and odontogenic maxillary sinusitis.Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.Alterations in cell signaling in sepsis.Limiting inflammatory responses during activation of innate immunity.Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections.Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.Src protein tyrosine kinase family and acute inflammatory responses.IRAK4 deficiency promotes cardiac remodeling induced by pressure overload.Microarray and whole-exome sequencing analysis of familial Behçet's disease patientsThe involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammationImpaired M. tuberculosis-mediated apoptosis in alveolar macrophages from HIV+ persons: potential role of IL-10 and BCL-3IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American WomenMycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway.Effects of porcine MyD88 knockdown on the expression of TLR4 pathway-related genes and proinflammatory cytokines.Linking oxidative stress to inflammation: Toll-like receptors.Elucidation of XA21-mediated innate immunity.Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.Current views of toll-like receptor signaling pathways.The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics.Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken.Receptor signaling in immune cell development and function.
P2860
Q24320454-AA9CBB1A-3BCD-4D48-B412-11FC7306E8CFQ24322734-9F9000F3-A7FA-43B2-9D14-91F38973484AQ27025156-D1FC40F9-E0EA-43D0-B733-CBA816FA7496Q28201815-35913834-D6AB-4E80-86D2-64BB18FF754AQ28290224-81B155CD-5CC5-4981-A3D1-FF11B266D434Q28587563-33FBDBCB-243B-47DA-BEC3-61C58DA6B97CQ33371955-EE71786A-53A6-4FC6-AF9C-EFBC7661A8F6Q33745132-C13BFDDC-52A7-4D70-AB75-433E278821BFQ35012945-2AF229B0-0A7F-4EC1-A037-C5CED9689D4AQ35047901-C1B4D45A-C9E9-4BC6-80EE-47B8C8FE7A85Q35058278-CD37878D-D640-4363-BB6A-FAAF2C438BBEQ35090141-8A3C8B50-18B3-4700-8603-3FB37E2A8310Q35121711-C5A1DDBA-36AA-46EA-93AD-7E592D572562Q35169333-9A62EC28-30D2-4B3B-993C-59CC5587EA91Q35267987-777D4C14-6644-4279-A8B8-AA6576A17476Q35745161-DC8F7F56-99FE-4ED5-9682-51A766139B52Q35884180-5CCC433C-8964-4FA1-9345-4509CAAD1680Q36118911-C204B512-B35E-4E80-B187-E99EA0ABE3D0Q36202827-7EFEE311-4B23-4A34-9B44-6A67080D12CDQ36291729-B64C89F1-58EA-4AF7-B1AD-5438F7534B3EQ36348742-60074A1B-240C-4C6E-86D4-2E23B37D271BQ36371624-DAD3F623-8AF5-4FD5-B620-7111F07BA76DQ36396820-2B46ACFA-CAF4-49D0-8408-FE82C7813A64Q36421994-99BCED74-03BB-48C1-90B4-76347FE049EBQ36438267-AD986A01-53FE-4EDB-AF15-72CDFD4A6945Q36492742-1669A131-1AC4-4FAE-9159-8FE05FA33024Q36500592-5EB87F61-CA60-48B3-BA76-F1FF67AC5318Q37076790-625E8735-3336-45C6-BC47-9B592902E835Q37247573-5B6E8315-6D3C-4D30-B505-7CA8FE20336BQ37261748-22CF7229-EEB9-4DDC-AB26-1D259A06527AQ37450890-519CDC53-E386-4AD1-AF3A-3ED4DECC66B6Q37626848-AE16E3E1-C633-44DE-84F0-32FC1DA9157FQ37677270-DEF04005-C4F3-4B53-B484-92932E9A7634Q37768805-290C4C38-5A26-442D-B9E7-05BC824E7401Q37769441-877FD5A5-6816-405C-A8DB-656166A6B563Q37825431-975DE0B0-82C5-4F6A-B871-2293502FC16CQ37899787-91BA2137-A13F-4CBE-9B98-AAFDEDEFBC99Q38180851-3514E0BF-BA27-47C5-95F2-5BDFBFF2DEDAQ38214121-368D2E99-7BD2-42B9-9F83-E5F32B328462Q38711461-642FEC3F-1D0E-4C1F-8AC5-D83DE369B2B8
P2860
IRAK-4 as the central TIR signaling mediator in innate immunity
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Oktober 2002 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/10/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/01)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
مقالة علمية (نشرت في أكتوبر 2002)
@ar
name
IRAK-4 as the central TIR signaling mediator in innate immunity
@ast
IRAK-4 as the central TIR signaling mediator in innate immunity
@en
IRAK-4 as the central TIR signaling mediator in innate immunity
@nl
type
label
IRAK-4 as the central TIR signaling mediator in innate immunity
@ast
IRAK-4 as the central TIR signaling mediator in innate immunity
@en
IRAK-4 as the central TIR signaling mediator in innate immunity
@nl
prefLabel
IRAK-4 as the central TIR signaling mediator in innate immunity
@ast
IRAK-4 as the central TIR signaling mediator in innate immunity
@en
IRAK-4 as the central TIR signaling mediator in innate immunity
@nl
P2093
P3181
P1433
P1476
IRAK-4 as the central TIR signaling mediator in innate immunity
@en
P2093
Nobutaka Suzuki
Shinobu Suzuki
Wen-Chen Yeh
P304
P3181
P356
10.1016/S1471-4906(02)02298-6
P577
2002-10-01T00:00:00Z